Approvals/TGA/PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial

Approved

STANDARD

PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0ace78959e2ca9bc
Product Name: PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial
Artg Id: 289796
Artg Name: PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2018-06-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/6202806f949d9dc58dfb854f3db31180.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1d9b719931d8850d147b3d4c186a0d7f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0ace78959e2ca9bc

Type

Standard